HDAC inhibition has been shown to rescue ischemia-induced DMD-signature alteration and improve phenotype in mdx mice, suggesting that DMD-signature miRNAs may serve as useful markers for therapeutic purposes [175]. Here, HDAC9 is linked to Duchenne muscular dystrophy.